Purification and characterization of a melanoma cell plasminogen activator.
about
Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR.The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin.The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domainsTranslational initiatives in thrombolytic therapy.Plasminogen activation: biochemistry, physiology, and therapeutics.Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells.Increased expression of alpha-enolase in c-jun transformed rat fibroblasts without increased activation of plasminogen.The glycosylation of Bowes melanoma tissue plasminogen activator: lectin mapping, reaction with anti-L2/HNK-1 antibodies and the presence of sulphated/glucuronic acid containing glycansExpression of human dopamine beta-hydroxylase in Drosophila Schneider 2 cells.An active zymogen: unravelling the mystery of tissue-type plasminogen activator.Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification.Clearance of the heavy and light polypeptide chains of human tissue-type plasminogen activator in rats.Large scale, rapid purification of recombinant tissue-type plasminogen activator.Different inhibition of one and two chain tissue plasminogen activator by a placental inhibitor studied with two tripeptide-p-nitroanilide substrates.Heterogeneity of human tissue-type plasminogen activatorIn silico and in vivo analyses of the mutated human tissue plasminogen activator (mtPA) and the antithetical effects of P19 silencing suppressor on its expression in two Nicotiana species
P2860
Q27329809-9CF26131-24B6-468A-9EE1-74CAE8DBF8A1Q29465797-3DD5DA01-207E-4313-B8D4-4C1C8A96B69DQ36586759-788FB235-5D65-4180-A356-4B26F20200BDQ39100187-863ED7B6-2A73-4129-9980-A09817272D75Q39489577-2EB7EA21-9365-4C6F-8698-459C74CEAABCQ40644152-5004BAA9-34A7-4BC8-B33B-05A68E238666Q41077404-1AA8931B-63D9-48DC-884F-CEA0E0EB7A25Q41195276-D4818DE8-03F9-4A44-8674-00A84BA7861EQ41256199-2294B087-B2F1-4337-BB7D-EE6E4E9580DAQ41730397-90D628BC-355B-4227-B3D2-5DB2DBD01EC1Q42149636-554A269B-0DBA-42A6-BB6B-F3111DEA83D6Q42801672-0B521F56-6A1D-4511-8A7B-7230E530F2BDQ42849229-EF81BF91-FF5C-4A0B-9A12-A681288957FFQ42854525-E78B1DBE-F3C1-473F-8894-4A9A85FDCA07Q50906518-810E0295-1F5F-4126-A301-1E25D393EEECQ53755999-1E9B582C-222B-4BA0-B94D-F54AFE96BCCBQ57584888-3261EB99-EDC1-454A-9A5A-463B6052D391Q58719633-8B68AA10-9CE9-4D3F-B913-B7FF2081AFD6
P2860
Purification and characterization of a melanoma cell plasminogen activator.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Purification and characterization of a melanoma cell plasminogen activator.
@en
Purification and characterization of a melanoma cell plasminogen activator.
@nl
type
label
Purification and characterization of a melanoma cell plasminogen activator.
@en
Purification and characterization of a melanoma cell plasminogen activator.
@nl
prefLabel
Purification and characterization of a melanoma cell plasminogen activator.
@en
Purification and characterization of a melanoma cell plasminogen activator.
@nl
P2093
P1433
P1476
Purification and characterization of a melanoma cell plasminogen activator.
@en
P2093
P2860
P304
P356
10.1111/J.1432-1033.1983.TB07418.X
P407
P577
1983-05-01T00:00:00Z